OverviewSuggest Edit

ArsenalBio is a  programmable cell therapy company. It aims to integrate technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop immune cell therapies, initially for cancer.

HQSouth San Francisco, US


ArsenalBio is headquartered in
South San Francisco, United States

Location Map

Latest Updates

Employees (est.) (Feb 2020)32(+29%)

Key People/Management at ArsenalBio

Jane Grogan

Jane Grogan

Chief Scientific Officer
Michael Kalos

Michael Kalos

EVP and Head of R&D
Ken Drazan

Ken Drazan

CEO, President, Director
Tarjei Mikkelsen

Tarjei Mikkelsen

Chief Technology Officer
Show more

ArsenalBio Office Locations

ArsenalBio has an office in South San Francisco
South San Francisco, US (HQ)
571 Eccles Ave
Show all (1)

ArsenalBio Financials and Metrics

Summary Metrics

Founding Date


ArsenalBio total Funding

$85 m

ArsenalBio latest funding size

$85 m

Time since last funding

4 months ago

ArsenalBio investors

ArsenalBio's latest funding round in October 2019 was reported to be $85 m. In total, ArsenalBio has raised $85 m
Show all financial metrics

ArsenalBio Online and Social Media Presence

Embed Graph

ArsenalBio Frequently Asked Questions

  • When was ArsenalBio founded?

    ArsenalBio was founded in 2019.

  • Who are ArsenalBio key executives?

    ArsenalBio's key executives are Jane Grogan, Michael Kalos and Ken Drazan.

  • How many employees does ArsenalBio have?

    ArsenalBio has 32 employees.

  • Who are ArsenalBio competitors?

    Competitors of ArsenalBio include Cyteir Therapeutics, Neurogastrx and Step Pharma.

  • Where is ArsenalBio headquarters?

    ArsenalBio headquarters is located at 571 Eccles Ave, South San Francisco.

  • Where are ArsenalBio offices?

    ArsenalBio has an office in South San Francisco.

  • How many offices does ArsenalBio have?

    ArsenalBio has 1 office.